136 related articles for article (PubMed ID: 16027801)
21. Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
O'Keefe JH; Stone GW; McCallister BD; Maddex C; Ligon R; Kacich RL; Kahn J; Cavero PG; Hartzler GO; McCallister BD
Am J Cardiol; 1996 Mar; 77(8):649-52. PubMed ID: 8610621
[TBL] [Abstract][Full Text] [Related]
22. [Reduction in the rates of restenosis after coronary angioplasty with simvastatin and probucol].
Merchán Herrera A; López Mínguez JR; Alonso Ruiz F; Escola JM; Címbora Ortega A; Poblador Curto MA; Redondo Méndez A; Romero Santisteban R; Geniz Gallardo I; González Fernández R; Millán Núñez V
Rev Esp Cardiol; 1999 Oct; 52(10):778-84. PubMed ID: 10563153
[TBL] [Abstract][Full Text] [Related]
23. [Antioxidant status and restenosis after stenting of coronary arteries].
Kaminnyĭ AI; Shuvalova IuA; Lankin VZ; Piksina GF; Shirokov RO; Samko AN; Kukharchuk VV
Kardiologiia; 2009; 49(4):14-8. PubMed ID: 19463112
[TBL] [Abstract][Full Text] [Related]
24. Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
Setsuda M; Inden M; Hiraoka N; Okamoto S; Tanaka H; Okinaka T; Nishimura Y; Okano H; Kouji T; Konishi T
Clin Ther; 1993; 15(2):374-82. PubMed ID: 8519045
[TBL] [Abstract][Full Text] [Related]
25. Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group.
Côté G; Tardif JC; Lespérance J; Lambert J; Bourassa M; Bonan R; Gosselin G; Joyal M; Tanguay JF; Nattel S; Gallo R; Crépeau J
Circulation; 1999 Jan 5-12; 99(1):30-5. PubMed ID: 9884376
[TBL] [Abstract][Full Text] [Related]
26. Effects of plaque composition on vascular remodelling after angioplasty in the MultiVitamins and Probucol (MVP) trial.
Lee HS; Tardif JC; Harel F; Côté G; Joyal M; Gosselin G; L'Allier PL; Doucet S; de Guise P; Lespérance J; Grégoire JC; Couturier A
Can J Cardiol; 2002 Mar; 18(3):271-5. PubMed ID: 11907616
[TBL] [Abstract][Full Text] [Related]
27. [Effect of probucol and losartan on growth factors after balloon angioplasty in rabbits].
Xu G; Li XS; Huang WQ; Huang H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):254-7. PubMed ID: 16706127
[TBL] [Abstract][Full Text] [Related]
28. Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART).
Mauri L; Reisman M; Buchbinder M; Popma JJ; Sharma SK; Cutlip DE; Ho KK; Prpic R; Zimetbaum PJ; Kuntz RE
Am Heart J; 2003 May; 145(5):847-54. PubMed ID: 12766743
[TBL] [Abstract][Full Text] [Related]
29. Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth.
Doggrell SA
Expert Opin Investig Drugs; 2003 Nov; 12(11):1855-9. PubMed ID: 14585060
[TBL] [Abstract][Full Text] [Related]
30. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty.
Sirtori CR; Franceschini G
N Engl J Med; 1997 Dec; 337(26):1918; author reply 1919. PubMed ID: 9417525
[No Abstract] [Full Text] [Related]
31. Pharmacologic approaches to restenosis prevention.
Douglas JS
Am J Cardiol; 2007 Sep; 100(5A):10K-6K. PubMed ID: 17719348
[TBL] [Abstract][Full Text] [Related]
32. [Mechanisms of anti-atherogenic action of probucol].
Ohya T; Egusa G
Nihon Rinsho; 1999 Dec; 57(12):2831-6. PubMed ID: 10638221
[TBL] [Abstract][Full Text] [Related]
33. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty.
Jay SJ
N Engl J Med; 1997 Dec; 337(26):1918-9; author reply 1919. PubMed ID: 9417526
[No Abstract] [Full Text] [Related]
34. Antioxidants and atherosclerosis: emerging drug therapies.
Tardif JC
Curr Atheroscler Rep; 2005 Feb; 7(1):71-7. PubMed ID: 15683606
[TBL] [Abstract][Full Text] [Related]
35. Frequency and time course of reocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus Wiktor stent implantation: results from the Mayo-Japan Investigation for Chronic Total Occlusion (MAJIC) trial.
Tamai H; Berger PB; Tsuchikane E; Suzuki T; Nishikawa H; Aizawa T; Fujii K; Nozaki Y; Kyo E; Kobayashi T; Reiber J; Van Weert AW;
Am Heart J; 2004 Mar; 147(3):E9. PubMed ID: 14999211
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological inhibition of coronary restenosis: systemic and local approaches.
Guerra E; Byrne RA; Kastrati A
Expert Opin Pharmacother; 2014 Oct; 15(15):2155-71. PubMed ID: 25145263
[TBL] [Abstract][Full Text] [Related]
37. Effects of probucol on restenosis after percutaneous coronary intervention: a systematic review and meta-analysis.
Liu J; Li M; Lu H; Qiao W; Xi D; Luo T; Xiong H; Guo Z
PLoS One; 2015; 10(4):e0124021. PubMed ID: 25898372
[TBL] [Abstract][Full Text] [Related]
38. Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis.
Sekiya M; Funada J; Watanabe K; Miyagawa M; Akutsu H
Am J Cardiol; 1998 Jul; 82(2):144-7. PubMed ID: 9678282
[TBL] [Abstract][Full Text] [Related]
39. [Prevention of postangioplasty restenosis].
Kitai T; Ishiwata S; Yamaguchi T
Nihon Rinsho; 2003 Apr; 61 Suppl 4():627-31. PubMed ID: 12735042
[No Abstract] [Full Text] [Related]
40. Role of probucol in preventing contrast-induced acute kidney injury after coronary interventional procedure.
Li G; Yin L; Liu T; Zheng X; Xu G; Xu Y; Yuan R; Che J; Liu H; Zhou L; Chen X; He M; Li Y; Wu L; Liu E
Am J Cardiol; 2009 Feb; 103(4):512-4. PubMed ID: 19195512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
